Sustainable Ecotourism through Cutting-Edge Technologies

Tourism is a phenomenon that dates back to ancient times. Ancient Greek philosophers recognised, adopted, and promoted the concept of rest-based tourism. Ecotourism is a particular type of tourism that connects with activities that take place in nature, without harming it, along with the herbal and animal wealth. According to estimates, the global ecotourism industry is currently booming due to various reasons, and it is becoming an important factor of sustainable regional development. This article presents the vision, work, and outcomes of project AdVENt, a project focusing natively in sustainable ecotourism through natural science and technological innovation. AdVENt’s study area includes the National Parks of Oiti (or Oeta) and Parnassus in Central Greece, where there is a remarkable native flora with a high endemism rate integrated with areas of cultural value and national and European hiking routes and paths of varying difficulty

Sustainable Ecotourism through Cutting-Edge Technologies

Tourism is a phenomenon that dates back to ancient times. Ancient Greek philosophers recognised, adopted, and promoted the concept of rest-based tourism. Ecotourism is a particular type of tourism that connects with activities that take place in nature, without harming it, along with the herbal and animal wealth. According to estimates, the global ecotourism industry is currently booming due to various reasons, and it is becoming an important factor of sustainable regional development. This article presents the vision, work, and outcomes of project AdVENt, a project focusing natively in sustainable ecotourism through natural science and technological innovation. AdVENt’s study area includes the National Parks of Oiti (or Oeta) and Parnassus in Central Greece, where there is a remarkable native flora with a high endemism rate integrated with areas of cultural value and national and European hiking routes and paths of varying difficulty

Bone marrow ribonucleotide reductase mRNA levels and methylation status as prognostic factors in patients with myelodysplastic syndrome treated with 5-Azacytidine

Ribonucleotide Reductase (RNR) is a two-subunit (RRM1, RRM2) enzyme, responsible for the conversion of ribonucleotides to deoxyribonucleotides required for DNA replication. To evaluate RNR as a biomarker of response to 5-azacytidine, we measured RNR mRNA levels by a quantitative real-time PCR in bone marrow samples of 98 patients with myelodysplastic syndrome (MDS) treated with 5-azacytidine with parallel quantification of the gene promoter's methylation. Patients with low RRM1 levels had a high RRM1 methylation status (p = 0.005) and a better response to treatment with 5-azacytidine (p = 0.019). A next-generation sequencing for genes of interest in MDS was also carried out in a subset of 61 samples. Splicing factor mutations were correlated with lower RRM1 mRNA levels (p = 0.044). Our results suggest that the expression of RNR is correlated with clinical outcomes, thus its expression could be used as a prognostic factor for response to 5-azacytidine and a possible therapeutic target in MDS